Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat

European Journal of Medical Research

Volumn 18, Issue 1, 2013, Pages

  Kumamoto, Ryo ^a   Uto, Hirofumi ^a   Oda, Kohei ^a   Ibusuki, Rie ^a   Tanoue, Shirou ^a   Arima, Shiho ^a   Mawatari, Seiichi ^a   Kumagai, Kotaro ^a   Numata, Masatsugu ^a   Tamai, Tsutomu ^a   Moriuchi, Akihiro ^a   Fujita, Hiroshi ^a   Oketani, Makoto ^a   Ido, Akio ^a   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Diethylnitrosamine; Fructose; Hepatocarcinogenesis; Nonalcoholic steatohepatitis; Placental form of glutathione S transferase

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; CHOLESTEROL; DIETHYLNITROSAMINE; DRINKING WATER; FRUCTOSE; GLUCOSE; GLUTATHIONE TRANSFERASE; INSULIN; MESSENGER RNA; TRIACYLGLYCEROL; 8 OXO 7 HYDRODEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; DRUG DERIVATIVE; CARBOHYDRATE DIET;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; FAT INTAKE; FATTY LIVER; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; LIPID DIET; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PRECANCER; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CARBOHYDRATE DIET; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INCIDENCE; METABOLISM; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT; ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES; DRUG EFFECTS; PHARMACOLOGY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; DEOXYGUANOSINE; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DIETHYLNITROSAMINE; FATTY LIVER; FRUCTOSE; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HEPATOCYTES; INCIDENCE; MALE; ORGAN SIZE; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84889828973     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-18-54     Document Type: Article

References (30)

1. Nonalcoholic steatohepatitis: definition and pathology. Brunt EM, Semin Liver Dis 2001 21 3 16 10.1055/s-2001-12925 11296695 (Pubitemid 32240482)
2. Inflammation and fibrogenesis in steatohepatitis. Fujii H, Kawada N, J Gastroenterol 2012 47 215 225 10.1007/s00535-012-0527-x 22310735
3. The natural history of nonalcoholic fatty liver disease: a population based cohort study. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P, Gastroenterology 2005 129 113 121 10.1053/j.gastro.2005. 04.014 16012941 (Pubitemid 41002048)
4. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K, J Gastroenterol Hepatol 2009 24 248 254 10.1111/j.1440-1746.2008.05640.x 19032450
5. Prevalence, gender, ethnic variations, and prognosis of NASH. Hashimoto E, Tokushige K, J Gastroenterol 2011 46 Suppl 1 63 69 20844903
6. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, Kure T, Tamai T, Moriuchi A, Sakiyama T, Oketani M, Ido A, Tsubouchi H, J Gastroenterol 2011 46 769 778 10.1007/s00535-011-0376-z 21302121
7. Steatohepatitis: a tale of two "hits"? Day CP, James OF, Gastroenterology 1998 114 842 845 10.1016/S0016-5085(98)70599-2 9547102 (Pubitemid 28160420)
8. Japan NASH Study Group, Ministry of Health, Labour, and Welfare of Japan: characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H, Takami S, Sumida Y, Takamura T, Kawanaka M, Okanoue T, Clin Gastroenterol Hepatol 2011 9 428 433 10.1016/j.cgh.2011.01.023 21320639
9. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Starley BQ, Calcagno CJ, Harrison SA, Hepatology 2010 51 1820 1832 10.1002/hep.23594 20432259
10. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Bray GA, Nielsen SJ, Popkin BM, Am J Clin Nutr 2004 79 537 543 15051594 (Pubitemid 41103894)
11. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Havel PJ, Nutr Rev 2005 63 133 157 10.1111/j.1753-4887.2005.tb00132.x 15971409
12. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Stanhope KL, Havel PJ, Curr Opin Lipidol 2008 19 16 24 10.1097/MOL.0b013e3282f2b24a 18196982
13. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ, Hepatology 2010 52 934 944 10.1002/hep.23797 20607689
14. Liver regeneration after partial hepatectomy in rat is more impaired in a steatotic liver induced by dietary fructose compared to dietary fat. Tanoue S, Uto H, Kumamoto R, Arima S, Hashimoto S, Nasu Y, Takami Y, Moriuchi A, Sakiyama T, Oketani M, Ido A, Tsubouchi H, Biochem Biophys Res Commun 2011 407 163 168 10.1016/j.bbrc.2011.02.131 21371432
15. Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Morimura S, Suzuki T, Hochi S, Yuki A, Nomura K, Kitagawa T, Nagatsu I, Imagawa M, Muramatsu M, Proc Natl Acad Sci USA 1993 90 2065 2068 10.1073/pnas.90.5.2065 8446629 (Pubitemid 23069998)
16. Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine. Matsuda M, Nakamoto Y, Suzuki S, Kurata T, Kaneko S, Lab Invest 2005 85 655 663 10.1038/labinvest.3700257 15765122 (Pubitemid 40675446)
17. Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD, Int J Cancer 2009 124 540 546 10.1002/ijc.23995 19004024
18. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. El-Serag HB, Tran T, Everhart JE, Gastroenterology 2004 126 460 468 10.1053/j.gastro.2003.10.065 14762783 (Pubitemid 38182303)
19. Enhancement of hepatocarcinogenesis in rats by dietary fructose. Enzmann H, Ohlhauser D, Dettler T, Bannasch P, Carcinogenesis 1989 10 1247 1252 10.1093/carcin/10.7.1247 2567639 (Pubitemid 19177228)
20. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S, Arch Intern Med 2006 166 1871 1877 10.1001/archinte.166.17. 1871 17000944 (Pubitemid 44455170)
21. Long-term follow up of patients with nonalcoholic fatty liver. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM, Clin Gastroenterol Hepatol 2009 7 234 238 10.1016/j.cgh.2008.11.005 19049831
22. Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Elmarakby AA, Faulkner J, Baban B, Sullivan JC, Int J Hypertens 2012 2012 957235 22518298
23. c-Jun terminal kinase-2 gene deleted mice overexpress hemeoxygenase-1 and are protected from hepatic ischemia reperfusion injury. Devey L, Mohr E, Bellamy C, Simpson K, Henderson N, Harrison EM, Ross JA, Wigmore SJ, Transplantation 2009 88 308 316 10.1097/TP.0b013e3181ae3067 19667931
24. Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage. Yu HP, Yang SC, Lau YT, Hwang TL, Surgery 2010 148 103 109 10.1016/j.surg.2009.12. 008 20117814
25. Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice. Hou HS, Liao CL, Sytwu HK, Liao NS, Huang TY, Hsieh TY, Chu HC, PLoS One 2012 7 44880 10.1371/journal.pone.0044880 23028657
26. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE, J Exp Med 2005 202 1703 1713 10.1084/jem.20051047 16365149 (Pubitemid 41815876)
27. Obesity and hepatocellular carcinoma. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM, Gastroenterology 2004 127 97 103 10.1053/j.gastro.2004.09.021 15508109 (Pubitemid 39423375)
28. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Huang BW, Chiang MT, Yao HT, Chiang W, Diabetes Obes Metab 2004 6 120 126 10.1111/j.1462-8902.2004.00323.x 14746577 (Pubitemid 38220104)
29. Acute changes in liver gene expression in the N-nitrosodiethylamine- treated rat. Suzuki T, Imagawa M, Yamada R, Yokoyama K, Kondo S, Itakura K, Muramatsu M, Carcinogenesis 1994 15 1759 1761 10.1093/carcin/15.8.1759 8055660 (Pubitemid 24262171)
30. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. Sirover MA, J Cell Biochem 1997 66 133 140 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.0.CO;2-R 9213215 (Pubitemid 27287423)